Role of modulator recognition factor 2 in adipogenesis and leptin expression in 3T3-L1 cells

Biochemical and Biophysical Research Communications

Volumn 366, Issue 2, 2008, Pages 551-555

  Dong, Jie ^a   Ishimori, Naoki ^a   Paigen, Beverly ^b   Tsutsui, Hiroyuki ^a   Fujii, Satoshi ^a,c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JACKSON LABORATORY   (United States)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Adipocyte; Adipokine; Differentiation; Insulin; Leptin; Modulator recognition factor

Indexed keywords

ADIPOCYTOKINE; DEXAMETHASONE; INSULIN; LEPTIN; MESSENGER RNA; MODULATOR RECOGNITION FACTOR 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LEPTIN; MICE; TRANSCRIPTION FACTORS;

MUS;

EID: 37449012218     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.002     Document Type: Article

References (23)

1. Watanabe M., Layne M.D., Hsieh C.M., Maemura K., Gray S., Lee M.E., and Jain M.K. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2α and Mrf2β. Circ. Res. 91 (2003) 382-389
2. Whitson R.H., Huang T., and Itakura K. The novel Mrf-2 DNA-binding domain recognizes a five-base core sequence through major and minor-groove contacts. Biochem. Biophys. Res. Commun. 258 (1999) 326-331
3. Whitson R.H., Tsark W., Huang T.H., and Itakura K. Neonatal mortality and leanness in mice lacking the ARID transcription factor Mrf-2. Biochem. Biophys. Res. Commun. 312 (2003) 997-1004
4. Lyon C.J., Law R.E., and Hsueh W.A. Adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
5. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
6. Mandrup S., and Lane M.D. Regulating adipogenesis. J. Biol. Chem. 272 (1997) 5367-5370
7. Auwerx J., Martin G., Guerre-Millo M., and Staels B. Transcription, adipocyte differentiation, and obesity. J. Mol. Med. 74 (1996) 347-352
8. Lehrke M., and Lazar M.A. The many faces of PPARγ. Cell 123 (2005) 993-999
9. Yamauchi T., Oike Y., Kamon J., Waki H., Komeda K., Tsuchida A., Date Y., Li M.X., Miki H., Akanuma Y., Nagai R., Kimura S., Saheki T., Nakazato M., Naitoh T., Yamamura K., and Kadowaki T. Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat. Genet. 30 (2002) 221-226
10. Mori T., Sakaue H., Iguchi H., Gomi H., Okada Y., Takashima Y., Nakamura K., Nakamura T., Yamauchi T., Kubota N., Kadowaki T., Matsuki Y., Ogawa W., Hiramatsu R., and Kasuga M. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 280 (2005) 12867-12875
11. Yang T.T., Suk H.Y., Yang X.Y., Olabisi O., Yu R.Y., Durand J., Jelicks L.A., Kim J.Y., Scherer P.E., Wang Y., Feng Y., Rossetti L., Graef I.A., Crabtree G.R., and Chow C.W. Role of transcription factor NFAT in glucose and insulin homeostasis. Mol. Cell Biol. 26 (2006) 7372-7387
12. Friedman J.M. Obesity in new millennium. Nature 404 (2000) 632-634
13. MacDougald O.A., Cornelius P., Liu R., and Lane M.D. Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) α, β, and δ genes in fully-differentiated 3T3-L1 adipocytes. J. Biol. Chem. 270 (1995) 647-654
14. MacDougald O.A., Cornelius P., Lin F.T., Chen S.S., and Lane M.D. Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein α and δ genes in 3T3-L1 adipocytes and white adipose tissue. J. Biol. Chem. 269 (1994) 19041-19047
15. Yamakawa T., Whitson R.H., Li S.-L., and Itakura K. Modulator recognition factor-2 is required for adipogenesis in mouse embryo fibroblast and 3T3-L1 cells. Mol. Endocrinol. [Eu Pub ahead of print] (2007)
16. Moitra J., Mason M.M., Olive M., Krylov D., Gavrilova O., Marcus-Samuels B., Feigenbaum L., Lee E., Aoyama T., Eckhaus M., Reitman M.L., and Vinson C. Life without white fat: a transgenic mouse. Genes Dev. 12 (1998) 3168-3181
17. Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y., Goldstein J.L., and Brown M.S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12 (1998) 3182-3194
18. Shimomura I., Hammer R.E., Ikemoto S., Brown M.S., and Goldstein J.L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 (1999) 73-76
19. Gavrilova O., Marcus-Samuels B., Leon L.R., Vinson C., and Reitman M.L. Leptin and diabetes in lipoatrophic mice. Nature 403 (2000) 850-852
20. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K., Miki H., Tsuchida A., Akanuma Y., Nagai R., Kimura S., and Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J. Biol. Chem. 276 (2001) 41245-41254
21. Tsuchida A., Yamauchi T., and Kadowaki T. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor γ, CREB-binding protein, and adiponectin. J. Pharmacol. Sci. 97 (2005) 164-170
22. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., and Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297 (2002) 240-243
23. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A.J., DePaoli A.M., Reitman M.L., Taylor S.I., Gorden P., and Garg A. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346 (2002) 570-578